Article Information
History
- July 10, 2020.
Article Versions
- Version 1 (May 12, 2020 - 08:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Adrián Sánchez-Montalvá, MD, PhD1,8,9,*,
- Júlia Sellarés-Nadal, MD1,
- Juan Espinosa-Pereiro, MD1,8,
- Nuria Fernández-Hidalgo, MD, PhD1,10,
- Santiago Pérez-Hoyos, PhD2,
- Fernando Salvador, MD, PhD1,8,9,
- Xavier Durà, MD1,
- Marta Miarons, Pharm D, PhD3,
- Andrés Antón, PhD4,10,
- Simeón Eremiev-Eremiev, MD1,
- Abiu Sempere-González, MD1,
- Arnau Monforte-Pallarés, MD1,
- Pau Bosch-Nicolau, MD1,
- Salvador Augustin, MD, PhD5,
- Júlia Sampol, MD6,
- Alfredo Guillén-del-Castillo, MD, PhD7 and
- Benito Almirante, MD, PhD1,10
- 1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
- 2Statistic Unit, Vall d’Hebron Institute of Research, Barcelona, Spain
- 3Pharmacy Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
- 4Microbiology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
- 5Hepatology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
- 6Pneumology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
- 7Internal Medicine Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
- 8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain
- 9Tropical Medicine Spanish Research Network (RICET), Madrid, Spain
- 10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain
- ↵*Address correspondence to:
Adrián Sánchez-Montalvá, MD, PhD (corresponding author), Address: Passeig Vall d’Hebron, 119-129. Hospital Universitario Vall d’Hebron. Edificio General. Enfermedades Infecciosas. 6a planta. CP 08035. Barcelona. Spain., e-mail: adsanche{at}vhebron.net. Telephone number: +34 93 274 6090 Fax number: +34 93 489 40 91.
Posted July 10, 2020.
Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study
